Galera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

For more information, visit Galera Therapeutics or follow their updates on:

Galera Therapeutics Articles

Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

mm
EQ Staff, Jonathan Allen
3 Min Read

Loading

-
275
Visitors
Dollar sign fundraising

12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

mm
Tanya Yatzeck
4 Min Read

Loading

-
1,334
Visitors
BioGenerator

Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

mm
Tanya Yatzeck
3 Min Read

Loading

-
258
Visitors

Veniti’s CFO Catherine Matthes on Clinical Trial Funding

mm
Tanya Yatzeck
4 Min Read

Loading

-
316
Visitors

Robert Beardsley on Galera Therapeutics’ High Growth

mm
Tanya Yatzeck
3 Min Read

Loading

-
1,715
Visitors